J&J Innovation launches intratumoral cancer treatments QuickFire Challenge
JNJ•QuickFire Challenge finalist session planned for Seoul
- Johnson & Johnson Innovation-JJDC will host a closed-door finalist session in Seoul on Nov. 13, 2026 for its intratumoral treatments challenge.
- Finalists unable to attend in person may present virtually in November 2026.




